:
1. , ( 1 ), : ( ), , .
2. - .
3. .
, , 1 . , , .
, . . . , . (, , ) 2-6 . : , , .
.
, ; , / . .
1. , .
2. , :
- ;
- ;
- .
:
- . , - ;
- : ,, 3, -, ;
- : , , , , .
:
- , , ;
- 7 .
|
|
:
- / ;
- .
, | ||||
, , | , , | , | ||
, , | , , | 3 | ||
, , , , | , , , , , , , | , , . | , . . | |
, . , | , |
: .
(7):
- .
- , .
- , /. , .
- , ( / ) ( ). , , , .
- 18-24 (,8).
- , , .- (84 ). , - , . , ( 0.47; 95% () 0.17 to 1.30). , . , , . , , , (9,10).
|
|
. , . FDAD ( - , . , , ).
. , . FDAD. ( , . , ).
. , , , , . FDA . ( , / , ).
- , , () , - , , , 54% ( [] 0,46, 95% []: 0,29 - 0,71) . (LMW) , 35% ( 0,65, 95% : 0,49 - 0,86). , , , . (, , ) . - , (11,12,13,14).
, .
: , .
: :
(. ) - , , 3, -, .
|
|
: , .
: .
24 . , Gilles (15) 800 79% ( 87% - 30- ). (10-24 ) - 200 12 ( Jain (16)).
: 14-16 - (17,18,19).
, .
, :
- ( FDA) 200-400 1-II .
- () FDA D, () 1 (90 ) , , 30 .
- ( FDA) 10 2 16-20 .
- .
-
- - .
- , , , .
- (Sapporo, 1999) c (MiyakisS.Etal.,2006): : , , , , , , .
:
1.
2. : - 10 , 34 - , 10 ( , , ).
- , .
- , , 3, -, .
:
) ( ) ;
|
|
) :
- 1- , , 2- ;
- ;
- , , .
. , , 70-80% ( ). . ( ) . , - , 3 , 3 ;. 200-400 20 .
. , 2- / , 3- . , .
) ( ) :
- ,
- - ,
- , , , ;
- IgGIgM ;
- 7-8 , .
) , , , .
:
- .
- .
:
- - ; .
I. , 2013
1. 1. Royal College of Obstetricians and Gynaecologists.The management of Early Pregnancy Loss. Green-top Guideline No. 25. London: RCOG 2006. 2.Nilsson IM, Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant (antithromboplastin). Acta Medicine Scandinavia 1975;197:153159. 3.Lynch A, Marlar R, Murphy J, Davila G, Santos M, Rutledge J et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study.Annals of Internal Medicine 1994;120:470475. 4.Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstetrics and Gynecology 1995;86:555559. 5.Rand JH, Wu XX, Andree H, Lockwood C, Guller S, Scher J et al. Pregnancy loss in the antiphospholipid-antibody syndrome a possible thrombogenic mechanism. New England Journal of Medicine 1977;337:154160. 6.Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertility and Sterility 1996;66:540546. 7. , , , 2003 8.Hassan S.S., Romero R., Vidydhari D. et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, doubl-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011, Jul; 38 (1): 18-31 9.Wahabi HA, Abed Althagafi NF, Elawad M. Progestogen for treating threatened miscarriage. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD005943. DOI: 10.1002/14651858.CD005943.pub2 10.Wahabi H.A., Abed Althagafi N.F., Elawad M. et al. Progestogen for treating threatened miscarriage. Cochrane Database Syst. Rev. 2011.-Vol.16, 3. CD00594 11.Rand JH, Wu XX, Andree H, Lockwood C, Guller S, Scher J et al. Pregnancy loss in the antiphospholipid-antibody syndrome a possible thrombogenic mechanism. New England Journal of Medicine 1977;337:154160. 12.Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertility and Sterility 1996;66:540546. 13.Lynch A, Byers T, Emlen W, Rynes D, Shetterly SM, Hamman RF. Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy. Obstetrics and Gynecology 1999;93:193198. 14.Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and antiphosphatidylserine antibodies in women with recurrent abortion. Indian Journal of Medical Sciences 2005;59:347352. 15.Gilles JM, Creinin MD, Barnhart K, Westhoff C, Frederick MM, Zhang J. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for the first-trimester pregnancy failure. Am J Obstet Gynecol2004;190:389. 16.Jain JK, MishellDRl. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol1996;175:173. 17.Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). The Cochrane Library Issue 3, 2006;Chichester, UK: John Wiley & Sons. 18.Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant; medical or surgical? Results of a randomised controlled trial (the MIST trial). BMJ 2006;332:1235-1238. 19.Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). The Cochrane Library Issue 3, 2006;Chichester, UK: John Wiley & Sons.
|
|
III.
:
.. ..., , .
.. ..., , .
:
. , ..., . ..
: .
: , 1 5 , , .
3. . . . . .
() , , , .
:
:
- 45 , ,
10 , , , , . - 20 , , , , , , , .
:
, .
, , , .
, , ; , , ( ).
:
: , .
: , .
: .
4. . . , .
, .
: ; ; .
:
;
, ( );
( );
( );
, ;
(, , , ) ;
( , , , , , , (, ) ;
;
;
;
;
, ;
; : , .
:
()
≥140 ...
/ ≥90 ... 30
≥110 ... 30 ;
≥160 ... 30 ; - > 0.3 / 0,3 / , 4 .
- 50-80% . , , , . , , .
:
5. . .. .
() , .
:
- , , ;
- , , ;
- ( ).
( ) .
: , .
:
.
( ) .
, , . , .
, . - .
. , .
. , , .
:
, , , (, ) . ,
- ;
- ( ) ( );
- ;
- 300 ;
- , ;
: , , . , , , . ;
, , .
6. . .. .
, ( ). 0,1 1% . , , .
( );
( );
( 5 , 7 ).
. , . .
, , :
( );
( , , , ).
, . :
;
;
;
;
;
( , );
( , );
;
;
35 ;
;
;
;
.
. ( , ). , . , 24 , , . , . , . , , ( , , ). , , , , , , ().
. , .
. , , - ( ) . ( 1/3 ).
, , .
, , . , .
.
: - , .
.
I-II -. , ( , , . .)
24 . .
7. . .
. , . , , 3-4 . () . , . . - . , , , . , , .
: : , - . , ( , , : ). 3-4 . .
. , .
8. .
:
, ( , );
( 12 );
- (1 1 , 1 2-3 2 , 1 7-10 3 );
(, );
( , , );
( ( , , ) ( , )).
( 30 , , ).
:
o ;
o (, );
o ;
o - ( ( ) );
o () ;
o (, ) .
- . , . . . . , , . . 2 . , , ( , , ), , . , . , . . - .
, , . 3-4 . . , . 10 ( ). 6-8 . 3 .
. - . . , .
9. . . , . .
, , . , Gardnerellavaginalis, (Bacteroidesspp., Mobiluncusspp., Fusobacteriumspp., Peptostreptoicoccusspp., M. hominis, U. urealyticum).
, , . Gardnerellavaginalis , , . , , , , . , . . Gardnerellavaginalis.
Mycoplasmataceae Mycoplasmahominis Ureaplasmaurealyticum. 70% Ureaplasmaurealyticum Parvo, 23,3% 960. , Ureaplasmaurealyticum, Parvo, , , , , .
25% , () 3,1% [2].
- , , - . Gardnerellavaginalis . , Gardnerellavaginalis,
, 72 ( ); . 3 [3].
:
, Gardnerellavaginalis;
;
, , ( , );
( 1/3 ).
.
1. :
o ;
o , , ;
o .
2. : 3,84,5.
3. : ( 10%- )
4. :
o 106108 /;
o ;
o - (104 /) .
.
. 7- , , . (, , , ), , . . , . 22,5 . , . . : 2%- 5 ( ) 1 ( ) 6 ; 100 3 ; 300 2 / 7 .
2%- 5 ( ) 2 / 5 .
. , Trichomonasvaginalis, Entamoebahistolytica . :
0,75% 5 ( ) ( ) 5 ;
500 2 / 7 ;
2 .
:
(-, -), 2 ;
. Candida, . , . , , . , .
. , , . , . . , (, , ), .
, , , . , -, , , . . .
;
;
;
.
, .
, . . :
1. : , , , -;
2. 3- ;
3. : , .
, , . . , . . , , . .
. . , . . .
, , , . , , , .
. , .
, . , . - . , , . . , . .
11. . . , .
̆ () , ̆ , ̆ ̆ , , , ̆ ̆ .
̆ ( , ), . ̆̆ ̆ ̆ , . , . ̆ ̆ ̆. ̆ ̆ . , , , ( ̆ ).
̆ ̆. ̆ 56 ̆ ̆ .
: , , . , , .
̆. , , , , , . ̈ ̆ , ̆. . , ̆ ( ), . ̆, ̈, ̆ ̆ .